Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2013
10/23/2013CN102485750B Plant anti-oxidation associated protein SsOEP8, coding gene thereof, and application thereof
10/23/2013CN102321171B Synthetic method of artificial antigen suitable for alkylphenol medicament
10/23/2013CN102178975B Fibrous protein hemostatic patch and making method thereof
10/23/2013CN102164949B Nonnatural protein
10/23/2013CN101993489B Reversible hirudin
10/23/2013CN101962402B Astragalus membranaceus glycoprotein as well as preparation method and usage thereof
10/23/2013CN101906158B Pegylation hypoglycemic polypeptide and preparation method and application thereof
10/23/2013CN101889089B Transgenic plants with increased stress tolerance and yield
10/23/2013CN101808731B Immobilisation of chelating groups for immobilised metal ion chromatography (IMAC)
10/23/2013CN101808658B Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action
10/22/2013US8563835 Maize variety inbred PH10MS
10/22/2013US8563831 Maize variety inbred PH17AN
10/22/2013US8563830 Maize variety inbred PH1C8A
10/22/2013US8563829 Maize variety inbred PH18HH
10/22/2013US8563828 Inbred maize variety PH17C4
10/22/2013US8563808 AXMI-003, a delta-endotoxin gene and methods for its use
10/22/2013US8563807 Hybrid spinach variety Andromeda
10/22/2013US8563713 Antibodies specific to carbamazepine
10/22/2013US8563705 Ribonucleic acid binding motif protein 20 sequence variants
10/22/2013US8563692 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
10/22/2013US8563689 Methods for regulating inflammatory mediators and peptides for useful therein
10/22/2013US8563688 Procoagulant peptides
10/22/2013US8563687 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins
10/22/2013US8563685 Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof
10/22/2013US8563684 Tumor antigen protein SART-3 and tumor antigen peptides thereof
10/22/2013US8563682 Guanylylcyclase C ligands
10/22/2013US8563521 Biological active proteins having increased in vivo and/or in vitro stability
10/22/2013US8563519 Methods of activating or inhibiting G protein coupled receptors (GPCRs)
10/22/2013US8563517 Dipeptidyl peptidase IV (DP-IV) compounds
10/22/2013US8563515 Tight junction protein modulators and uses thereof
10/22/2013US8563514 Peptides and pharmaceutical compositions for treating connective tissue
10/22/2013US8563508 Method for preventing or reducing acute renal failure by administration of therapeutically active α-MSH analogues
10/22/2013US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
10/22/2013US8563503 Antibiotic, its nucleotide sequence, methods of construction and uses thereof
10/22/2013US8563314 Methods and compositions for modulating PD1
10/22/2013US8563291 Method of constructing recombinant proteoliposome for diagnostic use
10/22/2013US8563288 Removal of plasmin or plasminogen from cryoprecipitate
10/22/2013US8563285 Isoforms of eIF-5A: senescence-induced eIF5A; wounding-induced eIF-5A; growth eIF-5A; and DHS
10/22/2013US8563273 Method of screening for compounds that disaggregate amyloid aggregates
10/22/2013US8563271 Antibodies specific for sclerostin and methods for increasing bone mineralization
10/22/2013US8563269 Modified antibody compositions, methods of making and using thereof
10/22/2013US8563249 Receptor gene screening for detecting or diagnosing cancer
10/22/2013US8563008 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/22/2013US8563007 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563006 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8562994 Human-murine chimeric antibodies against respiratory syncytial virus
10/22/2013US8562989 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
10/22/2013US8562984 Methods of treatment using anti-IL-20 antibodies
10/22/2013US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
10/22/2013US8562970 Modified CEA/B7 vector
10/22/2013US8562967 Stable liquid formulations of G-CSF
10/22/2013US8562948 Somatostatin analogs with inhibitory activity to growth hormone release
10/22/2013CA2707726C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/22/2013CA2571369C Antifungal polypeptides
10/22/2013CA2554089C Albumin fusion proteins
10/22/2013CA2550642C Oligonucleotide compound and method for treating nidovirus infections
10/22/2013CA2525698C A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein
10/22/2013CA2473526C Polyalkylene polymer compounds and uses thereof
10/22/2013CA2457488C Antimicrobial agent
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2405035C Improved method for the production of bacterial toxins
10/22/2013CA2367750C Tribonectins
10/22/2013CA2345375C Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
10/17/2013WO2013155481A1 Improved cellodextrin transport and mixed sugar fermentation
10/17/2013WO2013155205A1 Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
10/17/2013WO2013155109A1 Methods for generation of pluripotent and multipotent cells
10/17/2013WO2013154760A1 Chimeric antigen receptors targeting b-cell maturation antigen
10/17/2013WO2013154731A1 Protein scaffolds for selective enrichment of metal ions
10/17/2013WO2013154728A1 Genetically stable live attenuated respiratory syncytial virus vaccine and its production
10/17/2013WO2013154312A1 Method for producing a toxic protein by using laci protein mutant
10/17/2013WO2013154223A1 High concentration collagen and method for preparing same
10/17/2013WO2013153391A1 Polypeptide useful in adoptive cell therapy
10/17/2013WO2013153359A1 Mutant lysenin pores
10/17/2013WO2013153250A1 Glycosaminoglycan-binding of proteins with secret domain encoded by poxvirus
10/17/2013WO2013153214A1 Mutations in calmodulin genes
10/17/2013WO2013153179A1 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis
10/17/2013WO2013153090A1 Method for preparing and purifying a vegetable protein usable as a sweetener
10/17/2013WO2013153049A1 Polypeptides as apelin inhibitors and uses thereof
10/17/2013WO2013152418A1 System and method for multiphasic release of growth factors
10/17/2013WO2013105089A3 Anti-inflammatory peptides and use thereof
10/17/2013WO2013081571A3 Isolated lyssavirus nucleic acid and protein sequences
10/17/2013WO2013036636A8 Compositions and methods of treating cancer
10/17/2013WO2012118323A9 Fusion protein comprising albumin and a retinol-binding protein
10/17/2013US20130276167 Plant transcription factors
10/17/2013US20130276156 Multiple Inducible Gene Regulation System
10/17/2013US20130276155 Insecticidal Polypeptides and Methods of Use Thereof
10/17/2013US20130274437 Stabilized amyloid-beta oligomers and uses thereof
10/17/2013US20130274293 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
10/17/2013US20130274206 Compositions and Methods for Promoting Wound Healing and Tissue Regeneration
10/17/2013US20130274203 Anti-ssx-2 t cell receptors and related materials and methods of use
10/17/2013US20130274202 Peptides for Treating Cancer
10/17/2013US20130274201 Selective anticancer chimeric peptide
10/17/2013US20130274193 Tfpi inhibitors and methods of use
10/17/2013US20130274190 Biomaterial for wound healing and preparation thereof
10/17/2013US20130274189 VEGF Antagonist Formulations for Intravitreal Administration
10/17/2013US20130274186 Neurturin molecules
10/17/2013US20130274185 Pharmaceutical for Pseudo-Exercise Therapy
10/17/2013US20130274182 Engineered polypeptides having enhanced duration of action
10/17/2013US20130274173 Stable helical ionic polypeptides
10/17/2013US20130274172 Single domain tdf-related compounds and analogs thereof
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 2916